Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia

Meera Subramaniam1, Christine Bausch, Anne Twomey

  • 1Department of Medicine, Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Insights

Elevated bombesin-like peptides in premature baboons predicted lung injury, and blocking these peptides with 2A11 improved lung development and alveolarization, offering a potential BPD prevention strategy.

Area of Science:

  • Neonatal Physiology
  • Pulmonary Medicine
  • Developmental Biology

Background:

  • Bronchopulmonary dysplasia (BPD) incidence is rising despite advances in neonatal care.
  • Elevated bombesin-like peptide levels are observed in infants who develop BPD.
  • A previous study showed anti-bombesin antibody 2A11 mitigated lung injury in a 140-day hyperoxic baboon model.

Purpose of the Study:

  • To test if bombesin-like peptides mediate BPD in extremely premature baboons (125-day gestational age).
  • To evaluate the efficacy of anti-bombesin antibody 2A11 in a "modern-day BPD" model.

Main Methods:

  • Premature baboons (125-day gestational age) were treated with 2A11 on postnatal days 1, 3, and 6.
  • Lung histopathology was analyzed on postnatal days 14 and 21 for alveolarization.
  • Bombesin's regulation of angiogenesis was assessed using cultured pulmonary microvascular endothelial cells.

Main Results:

  • Urine bombesin-like peptide levels at postnatal days 2-3 correlated with impaired lung function at postnatal day 14.
  • Gastrin-releasing peptide mRNA was significantly elevated in 125-day PRN animals.
  • 2A11 treatment reduced alveolar wall thickness and improved alveolarization metrics (mean linear intercepts, branch points) by postnatal day 21.
  • Bombesin promoted endothelial cell tubulogenesis in vitro, an effect abrogated by co-cultured mesenchymal cells.

Conclusions:

  • Early overproduction of bombesin-like peptides predicts later alveolarization defects in premature baboons.
  • Blockade of bombesin-like peptides with 2A11 significantly improved lung septation and alveolarization.
  • These findings suggest a potential therapeutic strategy for preventing BPD in premature infants.
Abstract

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.